Search filters

List of works by Janusz Rolski

A multicenter, single-arm phase II study of pemetrexed plus doxorubicin administered every 21 days in patients with advanced breast cancer

scientific article published in August 2009

A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer

scientific article published in July 2008

Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study.

scientific article published on 24 August 2009

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.

scientific article

Chemotherapy of advanced non small cell lung cancer: effect on survival and symptoms affecting quality of life

scientific article published in January 2007

Diagnostic, predictive and prognostic verification of DNA flow cytometric measurements performed at diagnosis for non-Hodgkin's lymphoma adult patients

scientific article published on March 1, 2012

Effects of palliative treatment with temozolomide in patients with high-grade gliomas.

scientific article

Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo

scientific article published on 8 May 2009

First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland

scientific article published on 23 December 2020

Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study ⬇️

scientific article published on October 13, 2012

Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment

scientific article published in August 2008

Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study

scientific article

Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active th

scientific article

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes

scientific article published on 09 August 2009

Real-world treatment practice in patients with advanced melanoma

scientific article published on 03 July 2020

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2).

scientific article published on 15 July 2010

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study.

scientific article published on 25 May 2009

The case of giant rhabdomyosarcoma of the head and neck and meagre symptomatology ⬇️

scientific article published on September 1, 2010

The possibility of lapatinib treatment for breast cancer patients with central nervous system metastases. Case study and literature review

scientific article published on January 2012

Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.

scientific article published in June 2010

Paulina is supported by:

About Paulina

Help